MindAffect

MindAffect is a neurotechnology company based in Nijmegen, Netherlands, developing brain-computer interface solutions designed to restore communication for individuals with severe motor disabilities, including ALS and locked-in syndrome. The company's core technology centers on a code-modulated visual evoked potential (c-VEP) BCI system, which uses rapidly flickering visual stimuli to decode a user's intended selections based on brain signals captured through standard EEG headsets. Unlike many competing approaches, MindAffect's platform requires no prior user training and achieves high information transfer rates, making it both accessible and practical in real-world clinical settings. The company has also made its platform available as an open-source framework, enabling researchers and developers worldwide to build upon and extend its capabilities.

MindAffect has secured seed funding of approximately three million dollars to advance the development and commercialization of its technology. By leveraging consumer-grade EEG hardware rather than requiring proprietary or implanted devices, the company has positioned itself to offer a cost-effective and scalable alternative within the augmentative and alternative communication market. The open-source nature of their platform has helped build a growing community of academic and clinical collaborators, accelerating validation and expanding the breadth of potential applications. Their work has drawn attention from researchers in the BCI field who recognize the system's strong performance benchmarks relative to the simplicity of its hardware requirements.

MindAffect represents a meaningful advance for the broader neurotechnology industry by demonstrating that high-performance BCI communication does not necessarily depend on invasive hardware or lengthy calibration procedures. Their approach lowers the barriers to entry for both end users and clinical practitioners, addressing one of the most persistent challenges in translating BCI research into practical patient care. The company's commitment to open-source development also reflects a collaborative philosophy that has the potential to accelerate progress across the field rather than concentrating innovation within a single proprietary ecosystem. As the global population of individuals with progressive neurological conditions continues to grow, MindAffect's work highlights a viable and scalable path toward restoring agency and quality of life through neurotechnology.